Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-08-23
2011-08-23
Chen, Stacy B. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S204100, C424S218100
Reexamination Certificate
active
08003332
ABSTRACT:
Methods of inhibiting viral infection of a eukaryotic cell by a target virus having a class II virus fusion protein are provided. Also provided are methods of screening a test compound for the ability to inhibit infection by a virus having a class II viral fusion protein. Additionally provided herewith are aqueous-soluble proteins comprising a portion of a class II viral fusion protein comprising a Domain III of the viral fusion protein.
REFERENCES:
patent: 6682909 (2004-01-01), Nakano et al.
patent: 2004/0002582 (2004-01-01), Fox et al.
patent: WO 2004/052293 (2004-06-01), None
The International Preliminary Report on Patentability for PCT Application No. PCT/US2006/017284, dated Nov. 15, 2007.
Allison, et al., “Mapping of Functional Elements in the Stem-Anchor Region of Tick-Borne Encephalitis Virus Envelope Protein E.” Journal of Virology, 73:7, Jul. 1999, pp. 56-05-5612.
Bhardwaj, et al., “Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein.” Journal of Virology, 75:8, Apr. 2001, pp. 4002-4007.
Garry, et a;., “Proteomics Computational Analyses Suggest that the Carboxyl Treminal Glycoproteins of Bunyaviruses are Class II Viral Fusion Protein (Beta-Penetrenes).” Theoretical Biology and Medical Modelling, 1:10, 2004, pp. 1-16.
Zhang, et al., “Furin Processing and Proteolytic Activation of Semliki Forest Virus.” Journal of Virology, 77:5, Mar. 2003, pp. 2981-2989.
Samsonov, et al., “Effects of Membrane Potential and Sphingolipid Structures on Fusion of Semliki Forest Virus.” Journal of Virology, 76:24, Dec. 2002, pp. 12691-12702.
Chatterjee, et al., “Novel Mutations that Control the Sphingolipid and Cholesterol Dependence of the Semliki Forest Virus Fusion Protein.” Journal of Virology, 76:24, Dec. 2002, pp. 12712-12722.
Gibbons, et al., “Molecular Dissection of the Semliki Forest Virus Homotrimer Reveals Two Functionally Distinct Reions of the Fusion Protein.” Journal of Virology, 76:3, pp. 1194-1205, (2002).
Gibbons, et al., “Multistep Regulation of Membrane Insertion of the Fusion Peptide of Semliki Forest Virus.” Journal of Virology, Apr. 2004, pp. 3312-3318.
Gibbons, et al., “Purification and Crystallization Reveal Two Types of Interactions of the Fusion Protein Homotrimer of Semliki Forest Virus.” Journal of Virology, 78:7, Apr. 2004, pp. 3514-3523.
Lu, et al., “In Vivo Generation and Characterization of a Soluble Form of the Semliki Forest Virus Fusion Protein.” Journal of Virology, 75:17, Sep. 2001, pp. 8329-9339.
Gordon, et al., “Quantitative Fluorescence Resonance Energy Transfer Measurements Using Flourescence Microscopy.” Biophysical Journal, 74, May 1988, pp. 2702-2713.
Stiasny, et al., “Involvement of Lipids in Different Steps of the Flavivirus Fusion Mechanism.” Journal of Virology, 77:14, Jul. 2003, pp. 7856-7862.
Kielian Margaret
Liao Maofu
Albert Einstein College of Medicine of Yeshiva University
Amster Rothstein & Ebenstein LLP
Chen Stacy B.
LandOfFree
Inhibition of membrane fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of membrane fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of membrane fusion proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2727821